We examine the health care industry’s increasingly tough business climate dominated by increasing costs and prices, tightening margins and capital, and staffing upheaval. This array of urgent, disruptive market forces mean that leaders must navigate an unusually high number of short-term crises and opportunities—and that strategic choices have an outsized impact on their long-term goals. We’ll discuss the market forces that leaders should be watching and the key strategic decisions that maximize health care organizations' ability to influence the industry’s future structure.

Recommended for all audiences.

Health care organizations have rapidly implemented new technologies in response to the ongoing Covid-19 pandemic. After this flurry of investment, it is only natural for organizations to slow their pace of adoption as they evaluate next steps. This potential lack of urgency, however, can backfire and derail future progress. We’ll explore why health care organizations must continue to advance their digital strategies in the face of staffing challenges, changing consumer demands, and an ever-evolving competitive landscape.

Recommended for all audiences.

Advancing health equity is a common goal across the industry, but lofty ambitions need to be supported by action. In this presentation, we will explore what an equitable organization looks like in practice, what barriers stand in the way of making that a reality, and how different parts of the industry must work together to create a more equitable future. More specifically, we will focus this session on what this means for health care organizations and their role(s) in advancing health equity.

Recommended for all audiences.

The future of value-based care is likely to be physician-centric, but also influenced by the financial realities of provider business climates. We will unpack current plan and provider attitudes on risk-based payment models, major challenges, and strategies for plans to support provider performance in value-based arrangements. Available starting July 2023.

Recommended for all audiences.